Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Ealign Patientportal Deprescribing

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07454824Not ApplicableRecruiting

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

NCT02570945Phase 4CompletedPrimary

Trial of a Pharmacist-physician Intervention Model to Reduce High-risk Drug Use by Hospitalised Elderly Patients

Showing all 2 trials

Research Network

Common Treatments

  • Ealign Patientportal Deprescribing1
  • Pharmacistphysician Intervention To Reduce Highrisk Medication Use By Elderly Inpatients1

Active Sponsors

  • Centre de recherche du Centre hospitalier universitaire de Sherbrooke1
  • Johns Hopkins University1
  • National Institute on Aging (NIA)1

Top Investigators

Related Conditions

  • Mild Cognitive Impairment Mci1
  • Dementia1

Activity Timeline